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Production and cytokine-mediated regulation of monocyte
chemoattractant protein-i by human proximal tubular
epithelial cells
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Production and cytokine-mediated regulation of monocyte chemoat-
tractant protein-i by human proximal tubular epithelial cells. Impair-
ment of renal function in various types of glomerular disease is associated
with tubulointerstitial changes. The mechanism of mononuclear cell
infiltration in the interstitium is not fully understood. Recently, Inonocyte
chcmoattractant protein-i (MCP-1) has been identified as a monocyte-
specific chemotactic factor. We analyzed the presence of MCP-1 in renal
biopsies from patients with various forms of glomerular disease and
demonstrated that MCP-1 expression is increased in renal tubular epithe-
hal cells during disease. Further analysis showed that various cell lines of
human proximal tubular epithehial cells (PTEC) produce MCP-1 in
culture under serum-free conditions and that the production is inhibited
by cycloheximide. IL-la and TNF-a enhanced the production by each cell
line in a dose- and time-dependent manner as measured by radioimmu-
noassay. Northern blot analysis demonstrated that IL-ia and TNF-a
markedly enhanced the expression of MCP-1 mRNA. Taken together
these observations support the notion that MCP-1 is synthesized de novo
by PTEC. MCP-1 produced by PTEC is found to be 13 kD by gel filtration
chromatography. It is chemotactically active for monocytes. We conclude
that in various types of glomerular disease, MCP-1 expression in tubular
epithelial cells is associated with up-regulation of MCP-1 production by
PTEC. These findings raise the possibility that macrophages may accumu-
late in renal interstitium as a consequence of MCP-1 production by PTEC.
Progression of renal disease is characterized histologically by
glomerulosclerosis and tubulointerstitial changes. In various types
of glomerular disease, the degree of impairment of renal function
is associated with infiltration of mononuclear cells in the intersti-
tium, tubular atrophy, and interstitial fibrosis [1—4]. The intersti-
tial infiltrate consists mainly of T-lymphocytes, of a variable
number of macrophages and to a lesser extent of B cells [5—7].
Macrophages may play an important role in renal tissue damage
through the production of proteolytic enzymes, cytokines, and
growth factors such as interleukin-i (IL-i), tumor necrosis fac-
tor-a (TNF-a), transforming growth factor-a (TGF-13), and plate-
let-derived growth factor (PDGF) [8, 9]. Some of these factors
induce proliferation of fibroblasts and the production of extracel-
lular matrix leading to fibrosis [8, 10—13]. Lymphocytes are also
known to be involved in the development of interstitial fibrosis by
direct and indirect effects on fibroblasts [8, 14].
The mechanism by which mononuclear cells enter the intersti-
tium is not fully understood, but it is likely that chemotactic
factors and adhesion molecules are involved [15, 16]. Products
from PTEC might play an important role in the attraction and
accumulation of infiltrating cells. Enhanced expression of inter-
cellular adhesion molecule-i (ICAM-i) and HLA-class II anti-
gens on PTEC were found in different types of glomerular disease
in association with interstitial mononuclear cell infiltration [17,
18]. However, it is still unclear which stimulus is responsible for
the cellular infiltration in the interstitium. Monocyte chemoattrac-
tant protein-i (MCP-i) has recently been reported to have a high
degree of specificity as a chemotactic factor for monocytes. It was
purified from culture fluid of a human glioma cell line [19]. In vitro
studies have shown that MCP-i is produced by various cell types
such as mesangial cells [20], endothehial cells [21, 221, and
epithelial cells [23, 24] of human and animal origin.
The purpose of the present study is to determine whether
human PTEC produce MCP-1 and to evaluate the effect of the
inflammatory cytokines IL-la and TNF-a on the production of
MCP-1.
Methods
Reagents
Recombinant human MCP-1 (rHu-MCP-i) was purchased
from Peprotech, Inc. (NJ, USA). Anti-human MCP-1 antibody
was generated by immunization of a rabbit with rHu-MCP-1
conjugated to bovine thyroglobulin [25] in Freund's complete
adjuvant. Polyclonal IgG was isolated from immune rabbit sera by
precipitation with (NH4)2S04 followed by anion exchange chro-
matography on DEAE-Sephacel (Pharmacia LKB, Woerden,
NL). The MCP-i probe was obtained from freezed-dried E. coli
HB1O1-containing plasmid (ATCC 61364) and the GAPDH
probe was obtained from ATCC 78105.
Immunohistochemistiy
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Immunoperoxidase staining was performed on formalin-fixed
paraffin-embedded renal biopsies from three patients with mem-
branous nephropathy, three with membranoprohiferative glomer-
ulonephritis (GN), three with IgA nephropathy, and three with
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Fig. 1. A. Mo,phological appearance of human
proximal tubular epithelial cells (PTEC) in
culture (X200). B. Immunofluorescence staining
was observed in PTEC cultured using
monoclonal antibody directed against
adenosine-deaminase binding protein (ADBP)
a marker for PTEC and goat-anti-mouse
conjugated to triiodo-rhodamine (X400). C. No
fluorescence was observed in the control
staining using mouse IgG (X400).
idiopathic focal and segmental glomeruloscierosis. As normal
controls, tissue from four pretranspiant biopsies were used.
Immunoperoxidase stainings were also performed using frozen
sections from the same biopsies.
Paraffin-embedded sections less than 5 x thick were adhered to
gelatin-covered glass and fixed overnight at 37°C. The sections
were deparaffinized through several steps in xylene, alcohol, and
distilled water. Endogenous peroxidase was blocked by placing
the sections in distilled water containing 0.3% H202 for 20
minutes. Proteolytic digestion was performed by incubating the
sections in 0.1% trypsin (Sigma) and 0.1% CaCI2 in distilled
water. Following three wash steps in phosphate-buffered saline
(PBS), the sections were incubated with 10 to 15% normal goat
serum (NGS) in PBS and 1% bovine serum albumin (BSA) for 10
minutes, then followed by 75 1id polyclonal IgG rabbit-anti-human
MCP-1 at a dilution of 1/20 in PBS and 1% BSA overnight.
Following three washes in PBS, the sections were incubated again
with NGS followed by incubation with swine-anti-rabbit IgG
conjugated to horseradish peroxidase (HRP) (Dako, Glostrup,
Denmark) at a dilution of 1/50 in PBS and 1% BSA for 30
minutes. After three washes in PBS, the sections were incubated
in 0.1 M Na-acetate buffer for five minutes, and then in a mixture
of 5% of 3-amino-9-ethylcarbazol (AEC) and 0.05% H2O2 in
Na-acetate buffer. The sections were counterstained with Mayer's
hematoxylin for 30 seconds and covered with Kaiser's glycerin-
gelatin (Merck 9242). The intensity of MCP-1 staining was scored
semiquantitatively on tubular epithelial cells using a three point
scale: + = weak, ++ = intermediate, and +++ = strong
intensity. A number of sections were stained both for MCP-1 and
CD68 as a marker for macrophages [26], using polyclonal anti-
MCP-1 and monoclonal anti-CD68 antibodies, respectively. Rab-
bit-anti-mouse IgG and swine-anti-rabbit IgG conjugated to HRP
(all from Dako) containing 10 to 15% normal human serum
(NHS), were used as second steps. On cryostat sections from the
same biopsy, immunofluorescence (IF) double staining for MCP-1
and adenosine-diaminase binding protein (ADBP) as a marker for
PTEC [27] were also performed. Goat-anti-rabbit conjugated to
fluoroisothiocyanat (FITC) and goat-anti-mouse triiodo-rhoda-
mine (TRITC) (all from Nordic, Tillburg, NL) containing 10 to
15% NHS were used as second steps.
Human PTEC culture
Human PTEC were obtained from kidneys not suitable for
renal transplantation for anatomical reasons or from pretrans-
plant biopsies. PTEC were cultured following the method de-
scribed by Detrisac et al [28] and characterized by light micros-
copy and immunofluorescence using various monoclonal antibodies
as previously described [27, 29, 301. Figure 1A shows the morpho-
logical appearance of PTEC in culture. Staining cultured PTEC
using anti-ADBP monoclonal antibody (MoAb designated 1071)
[27J, demonstrated a strong fluorescence in all cells (Fig. 1B),
while control staining with mouse IgG was negligible (Fig. 1C).
The cells were cultured in serum-free dulbecco's modified Eagle's
medium (DMEM) and HAM F12 in 1:1 ratio (Seromed, Bio-
chrom, KG, Berlin, Germany) supplemented with insulin (5
jxg/ml), transferrin (5 tg/ml), selenium (5 nglml), hydrocortisone
(36 ng/ml), 3,3',5 triiodo-L-thyronine (4 pg/mI), and epidermal
growth factor (10 ng/ml) (Sigma, St. Louis, MO, USA). Primary
PTEC cultures were grown on a matrix of bovine collagen
(Vitrogen, Collagen Corp., Palo Alto, CA, USA) and fetal calf
serum (FCS) (Gibco BRL, Grand Island, NY, USA).
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Table 1. Immunoperoxidase staining for MCP-1 in various types of
glomerular disease
Biopsy
no. Histological diagnosis
Renal tubular cells
(intensity of staining)
1 Normal kidney +
2 Normal kidney +
3 Normal kidney +
4 Normal kidney +
5 Membranous nephropathy + + +
6 Membranous nephropathy + + +
7 Membranous nephropathy + +
8 Membranoproliferative GN -1- +
9 Membranoproliferative GN + +
10 Membranoproliferative GN + +
11 IgA nephropathy + +
12 IgA nephropathy + + +
13 IgA nephropathy + + +
14 Idiopathic FSGS + +
15 Idiopathic FSGS + +
16 Idiopathic FSGS + + +
Abbreviation is: idiopathic FSGS, idiopathic focal and segmental gb-
meruloscierosis.
Symbols are: +, weak intensity; + +, intermediate intensity; ++ +,
strong intensity.
cultured with or without various concentrations of IL-la or
TNF-a. Each well received 1 ml of medium or medium containing
IL-la or TNF-a. Unless indicated otherwise, stimulation was
carried out for 72 hours. Supernatants were harvested and as-
sessed for MCP-1 content by inhibition radioimmunoassay (RIA).
At the same time cell numbers per well were determined using a
Coulter counter (Coulter Electronics, Mijdrecht, NL).
To illustrate the effects of IL-la and TNFa on the production
of MCP-1, PTEC were cultured for 48 hours in the presence of
IL-la or TNF-a together with IL-laRa (IL-la receptor antago-
nist) or anti-TNF-a antibody, respectively. In addition, three
different PTEC cell lines were cultured in the presence of IL-la
and anti-TNF-a antibody in the culture medium.
Inhibition of MC?-] synthesis by cycloheximide
PTEC monolayers were grown in 12 well-plates, washed and
preincubated with 1 or 10 j.tg cycloheximide per ml medium for
four hours. The cells were washed with PBS and incubated in
medium in the presence or absence of cycloheximide. Superna-
tants were obtained at 24, 48, and 72 hours. To exclude a possible
cytotoxic effect of cycloheximide on the cells, all wells were
washed in PBS and replaced with medium without cycloheximide
and cultured for an additional 48 hours followed by collection of
the supernatants. MCP-1 was assessed in all supernatants by RIA.
Fig. 2. A. A biopsy from patient with idiopathic FSGS (biopsy no. 16, Table
1) stained with rabbit-anti-human MCP-1 antibody. Strong intensity (+ + +)
of MCP-1 staining was observed in tubular epithelial cells (x400). B.
Weak intensity of staining for MCP-1 was observed in tubular epithelial
cells from a biopsy of normal kidney (biopsy no. 1, Table 1) (X400). C.
Staining using pre-immune rabbit IgG in a biopsy of patient with IgA
nephropathy (biopsy no. 12, Table 1) did not show any staining in tubular
epithelial cells (X400).
IL-la and TNF-a stimulation
PTEC were grown in 24-well plates (Costar, Cambridge, MA,
USA). When confluency was reached, the cells were washed and
Inhibition radioimmunoassay for the detection of MCP-1
MCP-1 was determined in supernatants and fractions using an
inhibition radioimmunoassay (RIA) essentially as described for
IL-2 [31]. Recombinant human MCP-1 was labeled with 125! [32]
to specific activities of 15 to 20 iCi/jLg. Each tube containing
10,000 to 20,000 counts per minute (cpm) of radiolabeled MCP-1
was incubated with a fixed dilution of rabbit IgG anti-human
MCP-1, or dilutions of a known standard of MCP-1, or samples.
Precipitation was performed by adding goat anti-rabbit IgG in 9%
polyethylenglycol (PEG) in RIA buffer. Radioactivity was mea-
sured in the precipitates using a gamma counter (LKB, Wallac,
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Fig. 3. A. MCP-1 -positive tubular epithelial cells were observed in a paraffin-embedded section of a biopsy from patient with idiopathic FSGS stained with
rabbit-anti-human MCP-1 antibody (X200). B. CD68-positive cells, as the measure for macrophages, were also present in the vicinity of MCP-1-positive
tubular epithelial cells, in the same biopsy (x200). Immunofluorescence double staining was performed on cryostat sections from the same biopsy.
Staining for MCP-1 was observed in tubular epithelial cells as well as in the glomerulus (C), while staining with anti-ADBP antibody was demonstrated
on the brush border of tubular epithelial cells in similar location as MCP-1 staining (D). Anti-ADBP antibody did not stain the glomerulus (C,D X250).
Finland). The number of cpm in the sample was converted using
the standard curve to concentrations of MCP-1 in the samples.
This assay gives a sigmoidal inhibition curve and detects MCP-1
between 300 pg per ml and 20 ng per ml.
Northern blot and PCR analysis
Total RNA was isolated from human PTEC grown in T25
culture flasks with medium in the presence or absence of IL-la
(250 pg/ml) or TNF-a (250 U/mI) according to Chomczynski [33].
Twenty micrograms of total RNA was size-fractionated by elec-
trophoresis through 1% agarose-formaldehyde gels, transferred to
nitrocellulose membrane (Gene Screen Plus; DuPont, Wilming-
ton, DE, USA) as described by Sambrook, Fritsch, and Maniatis
[34]. The blot was prehybridized using a standard method as
described by Church and Gilbert [35] for two hours at 65°C using
prehybridization solution (0.5 M Na-phosphate pH 7.2, 7% SDS,
1% BSA, 1 mi EDTA) and 0.1 mglml herring sperm DNA. The
cDNA probe specific for MCP-1 was labeled with cs-32P[dCTPJ by
random priming [361. MCP-1 probe was added to prehybridiza-
tion solution and the blot was hybridized [35] overnight at 65°C.
The blots were washed, and autoradiography was performed using
X-ray film (Eastman-Kodak, Rochester, NY, USA) and intensi-
fying screen at —80°C. After boiling, the same blot was rehybrid-
ized with a eDNA probe specific for glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH) labeled with a-32P[dCTPJ.
One microgram of total RNA obtained from PTEC after four
and eight hours of incubations in the presence or absence of IL-la
and TNF-cs were reversely transcribed into cDNA for PCR
analysis. Oligonucleotide primers were constructed from the
published eDNA sequence of MCP-1 [37]. The sequence of
MCP-l primer was (a) 5 'd(AACTGAAGCTCGCACTCTCG)3'
(coding sense) corresponding to bases 19 to 39 of cloned full
length sequence and (b) S'cI(TCAGCACAGATCTCCTTGGC)3'
(anticoding sense) which anneals to bases 256 to 276. The
enzymatic amplification of MCP-1 cDNA by PCR was performed
as modified by Saiki [38]. Amplification solution (50 mvt KC1, 10
mM Tris-HC1 pH 8.3, 2.0 mr'i MgC12, 2 mg/mI BSA, 0.25 m of
each dNTP), 1 d cDNA, 50 pmol of each primer and 2 U Taq
DNA polymerase were added to a final volume of 100 pA. The
mixture was heated for five minutes at 95°C followed by 33 cycles,
each of 2.5 minutes at 95°C, 1.5 minutes at 95°C and 1.0 minutes
at 72°C. PCR products were separated through 1% agarose gels,
transfered to hybond N membrane. The blot was hybridized with
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Table 2. Production of MCP-1 by different PTEC cell lines, in the
presence or absence of IL-la (250 pg/mI) or TNF-a (250 U/mI)
Cell lines
MCP-1 ag/i cells/24 hr
Medium Med + IL-la Med + TNF-a
1 1.72 0.26 6.42 0.05 4.55 0.89 a
2 1.43 0.02 5.23 0.OY 5.19 1.03
3 3.39 0.20 5.95 0.Ola 4.62 0.09'
4 2.39 0.09 4.37 0.10k' 3.49 0.02'
5 3.31 0.11 5.61 0.22k' 4.58 0.56a
6 0.97 0.02 2.06 0.Ola 1.44 0.40
7 1.07 0.08 2.29 0.2P 2.25 0.56
Mean SD 2.04 1.00 4.56 1.75 a 373 4a
a P < 0.05 as compared to medium.
cDNA probe specific for MCP-1 labeled with
detected by autoradiography.
Size of PTEC MCP-1
a-32P[dCTPJ and
Concentrated supernatant of PTEC cultures was subjected to
gel filtration on a 26/60 FPLC Superdex G75 column (Pharmacia,
LKB, Biotechnology), equilibrated with 0.05 M Na-phosphate and
0.15 M NaC1, pH 7.2. Fractions were collected at a flow rate of I
ml per minute and were assessed for protein and MCP-1 content.
Bovine serum albumin (BSA; 66 kD), carbonic anhydrase (29
kD), cytochrome c (12.4 kD), and aprotinin (6.5 kD) were used to
calibrate the column.
Chemotactic assay
Chemotactic activity of supernatants from PTEC culture in the
presence or absence of IL-la was assessed using 48-well modified
Boyden-chambers [39]. Twenty-five microliter aliquots of the
supernatants from non-stimulated or IL-la stimulated PTEC
(cultured for 72 hr, containing 15.4 ng/ml and 29.8 ng/ml of
MCP-1, respectively, and assessed for MCP-1 content by radio-
immunoassay) with either 50 g./ml normal rabbit IgG or rabbit
IgG-anti-MCP-1 were placed in duplicate wells of the lower
compartments of the Boyden chambers. HEPES buffer containing
20 mivi HEPES, 132 mrvi NaC1, 6 mrvt KC1, 1.2 mM KH2PO4, 1 mM
MgSO4 7H20, pH 7.4 and osmolarity 280 to 290 mOsm/kg, to a
final concentration containing of 0.5% (wt/vol) human serum
albumin, 5.5 m glucose and 1 mivi CaC12. Peripheral blood
mononuclear leukocytes were obtained from healthy volunteers.
The responder cells were diluted in buffer, and 50 l containing
50,000 cells were added per well to the upper compartments of the
chamber. Two filters were placed between the lower and upper
chambers. The lower filter had pore size of 0.45 i.tm (Millipore,
Bedford, MA, USA; type HA) and the upper filter had a pore size
of 8 m (Sartorius AG, Goettingen, Germany; SM 113). After two
hours of incubation at 37°C, the upper filter was removed and
fixed in a mixture of butanol and ethanol (20/80%, vol/vol) for 10
minutes, and stained with Weigert solution. The filters were
dehydrated with ethanol and made transparent with xylene.
Migrating monocytes were counted using light microscopy; six
random fields (magnification X400) were counted for each dupli-
cate well. Recombinant human MCP-1 (rHuMCP-1) at concen-
tration of 10 and 50 ng/ml (1.2 and 6 n, respectively) were used
as positive controls. The chemotactic effect of 10 nM fMLP was
also tested. Results are expressed as a percentage of the total
monocytes that migrated through the filter relative to positive
control (6 flM rHuMCP-1). The value obtained for medium alone
was substracted from the experimental values.
Statistical analysis
Statistical analysis was performed using Student's t-test for
unpaired samples. A P value <0.05 was considered as significantly
different.
Results
Expression of MCP-1 in renal biopsies
To determine whether MCP-1 is expressed in renal tubular
epithelial cells, renal tissue from normal individuals and a number
of patients with various types of renal disease were analyzed for
MCP-1 expression. In sections of diseased kidneys, the intensity of
MCP-1 staining by tubular epithelial cells was strong (Fig. 2A and
Table 1) as compared to that in normal kidneys (Fig. 2B).
Pre-immune rabbit IgG did not show detectable staining (Fig.
2C). The intensity of MCP-1 staining in tubular epihelial cells
varied between 2+ and 3+ among the diseases studied (Table 1).
The results obtained using frozen material from the same biopsies
did not differ from the results described above. Staining using
rabbit-anti-MCP-1 and mouse-anti-CD68 antibodies demon-
strated interstitial infiltrating macrophages in the vicinity of
MCP-1-positive tubular epithelial cells (Fig. 3 A, B). Immunoflu-
orescence double staining from the same biopsy showed that
MCP-1 was present in a similar location as staining for ADBP as
a marker for PTEC (Fig. 3 C, D)
MCP-1 production by PTEC
Since immunohistology of renal biopsies indicated the presence
of MCP-1 in the cytoplasm of renal tubules in normal and
diseased kidneys, we investigated whether seven different primary
cell lines of PTEC were able to produce MCP-1 in vitro in the
presence or absence of IL-la or TNF-a. Cells cultured for 24
hours in medium alone clearly showed production of MCP-1
(Table 2) and the production of MCP-1 by each cell line was
up-regulated both by IL-la and TNF-a.
To determine the concentration of the cytokines needed for an
optimal up-regulation of MCP-1 production, PTEC were cultured
for 72 hours in the absence or presence of increasing concentra-
tion of IL-la or TNF-a and the supernatants assessed for MCP-1.
Both IL-la and TNF-a enhanced the production of MCP-1 in a
dose-dependent fashion, reaching optimal production with 250 pg
of IL-la per ml (Fig. 4A) and 250 U TNF-a per ml (Fig. 4B). The
in vitro production of MCP-1 by four different PTEC cell lines all
demonstrated a similar pattern.
The kinetics of production of MCP-1 by PTEC in the presence
or absence of IL-la or TNF-a is shown in Figure 5. The
up-regulatory effects of IL-la and TNF-a on the production of
MCP-1 were already demonstrable at 24 hours, and increased
over time.
The production of MCP-1 by IL-la or TNF-a stimulated PTEC
is inhibited in the presence of IL-laRa (50 g/ml) or anti-TNFa
antibody (50 j.gIml), respectively. IL-laRa inhibits the production
of MCP-1 by 87.7 0.8%, while anti-TNFa antibody inhibits the
production of MCP-1 by 67.1 3.3%. The presence of anti-TNFa
antibody together with IL-la does not result in inhibition of the
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Fig. 5. Kinetics of MCP-1 production by PTEC in the presence or absence of
IL-la or TNF-a. PTEC (cell line 1) cultured in the presence of 250 pg
IL-la per ml, or 250 U TNF-a per ml showed a time-dependent
up-regulation of MCP-l production. Symbols are: (—•—) medium;
(—0—) medium + IL-la; (—U—) medium + TNF-a. Values are
expressed as mean 1 SD from two independent cultures with duplicate
determinations.
effect of IL-la mediated production of MCP-1. These experi-
ments have been performed using three different PTEC cell lines
cultured for 48 hours.
Dc novo synthesis of MCP-1
To distinguish between possible release of MCP-1 from stored
sites or de novo synthesis, PTEC were cultured in the presence or
absence of cycloheximide. In the presence of cycloheximide (1 or
10 ig per ml) a clear reduction in the production of MCP-1 was
observed with both doses of cycloheximide (Fig. 6A). Following
incubation in the first step, all cells were washed and incubated in
medium without cycloheximide. The supernatants were assessed
for their MCP-l content. The effect of cycloheximide was fully
reversible (Fig. 6B). No indication of cell death was seen in the
first step, as assessed by LDH or trypan blue exclusion.
Northern blot and PCR analysis
Northern blot analysis demonstrated low levels of MCP-l
mRNA expression for nonstimulated PTEC after eight hours of
incubations. The presence of IL-la and TNF-a both markedly
induced the expression of MCP-1 mRNA (Fig. 7).
Amplification cDNA MCP-1 obtained from PTEC cultured for
four and eight hours in the presence or absence of IL-la or
20
15
0
10
5 u
TNF-a with the MCP-1 primer set, revealed a transcript of 258 bp.
All of these bands hybridized with a cDNA probe specific for
MCP-1 (data not shown).
Size of PTEC MCP-1
To obtain insight in the molecular size of MCP-1 produced by
PTEC, concentrated supernatant was fractionated by gel chroma-
tography using a Superdex G-75 column. The fractions were
analyzed for protein and MCP-1 content. The estimated size of
MCP-1 obtained from PTEC supernatant was 13 kD (Fig. 8).
Chemotactic activity of MCP-1
Using supernatants from nonstimulated PTEC, monocyte che-
motactic activity could be demonstrated. The ratio (%) ofmigrat-
ing cells between samples and positive control was significantly
higher using supernatants obtained from IL-ia stimulated PTEC
than supernatants from nonstimulated PTEC. Monocyte chemo-
tactic activity of supernatants from nonstimulated and stimulated
PTEC could be blocked by anti-human MCP-i antibody (Fig. 9).
Table 3 shows the number of migrating monocytes counted per six
high power fields. It is shown that formyl-peptide fMLP at a
concentration of 10 tiM induced migration of 29 1.4 monocytes
per six high power fields. The optimal migration of monocytes was
found at a concentration of 50 nglml of rHuMCP-1 (35.5 3.5
monocytes per 6 high power fields).
Discussion
In a number of glomerular diseases infiltration of mononuclear
cells is found within the glomeruli and in the interstitium. In
proliferative GN, macrophages as well as T-lymphocytes are
present in the glomeruli [40], while in almost all types of GN,
T-Iymphocytes with varying numbers of macrophages may be
found in the interstitium [5, 7]. However, the mechanisms under-
lying mononuclear cell infiltration remain unclear. Monocyte
chemoattractant protein-i (MCP-1) might play a role in chemo-
taxis of macrophages toward the interstitium. Of course, factors
other than MCP-1 may also be responsible for the recruitment of
monocytes into the interstitium. In an animal model of glomeru-
lonephritis it was reported that the expression of osteopontin
mRNA as well as protein levels were increased in both proximal
and distal tubules and correlated with accumulation of monocytes
[41]. Intercellular adhesion molecule-i (ICAM-1) and vascular
cell adhesion molecule-i (VCAM-1) have also been reported to
be up-regulated on glomerular as well as tubulointerstitial cells in
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Fig. 4. Effect of increasing concentrations of IL-
in (A) and TNF-a (B) on the production of
MCP-i by PTEC in culture. Both IL-la and
TNF-a enhanced the production of MCP-1 in a
dose-dependent manner. The values are
expressed as mean I SD from two
independent cultures with duplicate
determinations.
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1 2 3
Fig. 7. Northern blot analysis of mRNA isolated from unstimulated PTEC
after eight hours of incubation (lane 1). The expression of MCP-1 mRNA
of PTEC is up-regulated by IL-la (lane 2) and TNF-a (lane 3). Equal
amounts of RNA were loaded on the gel assessed with GAPDH
hybridization.
patients with glomerular diseases [15, 42—44]. Up-regulation of
these factors in tubular epithelial cells is associated with an
increased numbers of interstitial infiltrating macrophages [161. In
the present study, renal biopsies of patients with various types of
renal disease showed a stronger intensity of MCP-1 staining in
tubular epithelial cells than in normal kidneys. We have demon-
strated an association between the intensity of MCP-1 staining in
tubular epithelial cells and interstitial infiltration of macrophages
in biopsies of patients with membranous nephropathy, IgA ne-
phropathy, and focal and segmental glomerulosclerosis [45]. Fur-
thermore, the intensity of MCP-1 staining in tubular epithelial
cells in biopsies of patients with chronic ischemia, lupus nephritis,
and extracapillary proliferative GN were not significantly different
as compared to normal kidneys. In the present study, the expres-
sion of MCP-1 in renal tubular epithelial cells may be the result of
6
Cl)
4
. Fig. 6. A. Cycloheximide (1 and 10 igIml) inhibits2 ' the production of MCP-J by PTEC in culture.
5 Symbols are: (—0—) medium; (—U—) +
cycloheximide 1 xgIml; (—A—) + cycloheximide 10j.gIml. B. The production of MCP-1 is reversible
upon removal of cycloheximide. Symbols are: ()0 medium; (•) + cycloheximide 1 xg/ml; (E) +
cycloheximide 10 sgIml. The values are expressed as
mean 1 SD from three independent cultures with
duplicate determinations.
reabsorption of filtered MCP-1 or it can be synthesized locally.
Our findings suggest that MCP-1 is produced by tubular epithelial
— 28 s cells in situ. This is supported by the data obtained with Northern
blot analysis and by the fact that IL-la and TNF-a enhanced the
expression of MCP-i mRNA and stimulated production and
release of MCP-1 by PTEC in vitro. In addition, the inhibition of
18 s production of MCP-1 by cycloheximide also supports the notion
that MCP-l is synthesized de novo by PTEC.
It was previously found that various types of human cells such
as mesangial-, endothelial- and epithelial cells produce MCP-1 in
culture [20, 21, 24, 46, 47]. The presence of cytokines or growth
factor such as IL-la, IL-113, TNF-a, IL-4, IFN-y, and PDGF are
known to stimulate the production of MCP-1 in vitro. Most studies
were performed using mesangial cells, as well as endothelial cells
obtained from umbilical veins. A study using human renal cortical
cells cultured in serum-containing medium showed increased
GAPDH
expression of MCP-i mRNA in the presence of IL-ip, TNF-a,
LPS, and IFN-y [24]. Since fetal calf serum (FCS) is known to
contain PDGF with mitogenic activity comparable to human
serum [48] other factors than the above cytokines might have been
responsible for the observed stimulation of MCP-1 production
[49, 50]. In this study PTEC was cultured in serum-free medium.
We found that the production of MCP-1 is stimulated by IL-la
and TNF-a. Gamma interferon (IFN-y) also enhanced the pro-
duction of MCP-1 by PTEC (data not shown). The effects of IL-la
and TNFa on the production of MCP-1 were inhibitable by
IL-i-Ra or anti-TNFa antibody. TNF-a is also produced by PTEC
after stimulation of IL-i-a and the presence of TNF-a in tubular
epithelial cells has been demonstrated before [51]. This latter
cytokine could potentially stimulate the production of MCP-1 by
PTEC. However, the presence of anti-TNF-a antibody did not
affect the production of MCP-1 by IL-la stimulated PTEC.
Another monocyte-specific cytokine is colony stimulating factor-i
(CSF-i). This factor is required for the survival, proliferation, and
activation of monocytes [52, 53]. Colony stimulating factor-i can
be produced by various types of cells including mouse mesangial
cells and human renal tubular epithelial cells [54—57]. In addition,
renal tubular epithelial cells are known to produce IL-8 as well.
The production of IL-8 was up-regulated by IL-l, TNF-a, and
LPS [24]. In a recent study, we also demonstrated that IL-8 is
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Fig. 9. Monocyte chemotactic activity of unstimulated and IL-irs stimulated
PTEC supernatants were assessed in a 48-well modified Boyden-chambers.
MCP-1 from PTEC, either stimulated or nonstimulated was inhibitable by
anti-human MCP-l and not by normal rabbit IgG.
produced by PTEC. The production of IL-8 is increased in the
presence of IL-irs and TNF-a, while IFNy down-regulates the
production of IL-8 (unpublished data).
The size of MCP-1 from PTEC as determined by gel filtration
chromatography is similar to the size of MCP-1 obtained from
fibroblast cell line MRC-5 and MCP-1 produced by glioma cell
line U105-MG as identified by Yoshimura and Leonard [501. The
molecular size of MCP-1 produced by the glioma cell line was
calculated to be 8.4 kD on the basis of the amino acid sequence,
but by SDS-PAGE the molecular size was found to be 15 kD and
13 kD [19]. The discrepancy in molecular size of MCP-1 deter-
mined by SDS-PAGE versus analysis on the basis of amino acid
sequence might be due to glycosylation [58]. It has been reported
that disaccharide galactose-1 to 3D-N-acetyl galactosamine is
present on the 13 kD isoform [59] which is identical to 15 kD as
identified by Yoshimura and co-workers [19]. It was also reported
that glycosylation did not affect the chemotactic activity. Our
study shows that MCP-1 produced by PTEC has chemotactic
activity for monocytes and that the activity could be blocked by
anti-human MCP-1 antibody.
The results obtained from this study raise the possibility that
MCP-1 produced by PTEC may, at least in part, be responsible for
8
6
AQ0
2
Table 3. Monocyte chemotactic activity of supernatants from PTEC
Agents in lower
chamber Concentration
No. of migrating cells
per six high power fields a
fMLP 10 nM 29 1.4
rHuMCP-l 6 flM 35.5 3.5
rHuMCP-1 1.2 nM 15 1.4
Supernatants
unstimulated PTEC 1.8 nsi 13 1.4
unstimulated PTEC
+ anti-MCP-1 (50 j.rg/ml)
stimulated PTEC 3.5 ntvi
3.5 0.7
18.5 0.7
stimulated PTEC
+ anti-MCP-1 (50 j.rg/ml)
Anti-MCP-1 (50 .rgIml)
3.5 0.71 0
a Presented as mean SD.
the accumulation of macrophages in renal interstitium of glomer-
ular diseases. In the present study, we found infiltrating macro-
phages in the vicinity of MCP-1-positive tubular epithelial cells
(Fig. 3 A, B) and evidence is presented that these cells are PTEC
(Fig. 3 C, D). The enhanced tubular production of MCP-1 in renal
diseases could be attributed to an autocrine effect of TNF-a
produced by PTEC [511 or to IL-la produced by macrophages [9].
We conclude that in various types of glomerular disease,
expression of MCP-1 in renal tubular epithelial cells is enhanced.
The enhancement of expression of MCP-1 might be due to
increased of local production of MCP-1 by renal tubular epithelial
cells. The presence of inflammatory cytokines such as IL-la and
TNF-a stimulate production of MCP-1 by PTEC in culture. This
finding is substantiated in the levels of mRNA and protein, using
Northern blot and radioimmunoassay analyses. In addition, inhib-
itory effect of cycloheximide on the production of MCP-1 support
the notion that MCP-1 is synthesized de novo by PTEC.
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